logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
V

Vahid Moazed

Kerman University of Medical Sciences
H指数:11
被引数:467
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial (vol 22, 960, 2022)
BMC CANCER
IF3.4
2022-12-220
OAAI
Allahyari, Abolghasem; Ehsanpour, Ali; Najafi, Behrouz; Ansarinejad, Nafseh; Mehrzad, Valiollah; Kalantari, Behjat; Raafat, Jahangir; Ghadiany, Mojtaba; Shahi, Farhad; Gharib, Behrooz; Moazed, Vahid; Khosravi, Adnan; Mirpour, Mir Hossein; Salari, Sina; Mortazavizadeh, Seyedmohammadreza; Nekoyi, Amirabbas; Khani, Mohsen; Sadeghi, Alireza; Gharib, Sirus; Bary, Alireza; Mirzania, Mehrzad; Haghighat, Shirin; Razavi, Seyed Mohsen; Emami, Seyed Amir Hossein; Hosseinzadeh, Mehran; Mirbolouk, Mahdi; Sadighi, Sanambar; Shahrasbi, Abdolali; Esfahani, Ali; Gity, Masoumeh; Anjidani, Nassim; Kaf, Hamidreza; Najaf, Safa

研究方向

暂未获取到该数据
G
Gholamreza Asadikaram
H 指数:27论文数:173被引数:2,617
M
Moslem Abolhassani
H 指数:16论文数:51被引数:711
H
Hossein Fallah
H 指数:13论文数:70被引数:700
P
Parisa Paydar
H 指数:9论文数:14被引数:377
H
Hamed Akbari
H 指数:20论文数:59被引数:1,530
E
Elham Jafari
H 指数:19论文数:176被引数:1,192
H
Hamid Zeynali Nejad
H 指数:5论文数:10被引数:112
A
Aliasghar Tirgar
H 指数:1论文数:6被引数:10
M
Mohammad Shabani
H 指数:35论文数:310被引数:5,544
N
Nouzar Nakhaee
H 指数:38论文数:266被引数:5,112